Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biolinerx Ltd ADR
(NQ:
BLRX
)
0.6520
-0.0331 (-4.83%)
Streaming Delayed Price
Updated: 3:58 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biolinerx Ltd ADR
< Previous
1
2
Next >
Bronstein, Gewirtz & Grossman, LLC Notifies BioLineRx Ltd. (BLRX) Investors of Class Action and to Actively Participate
January 17, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)
January 17, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX
January 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LONGSTANDING LAW FIRM, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX
January 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioLineRx, and Enovix and Encourages Investors to Contact the Firm
January 13, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Notifies BioLineRx Ltd. (BLRX) Investors of Class Action and to Actively Participate
January 13, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)
January 13, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors
January 12, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors
January 11, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors
January 10, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioLineRx Ltd. (BLRX) on Behalf of Investors
January 10, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioLineRx Ltd. (BLRX) on Behalf of Investors
January 09, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
BIOLINERX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioLineRx Ltd. and Encourages Investors to Contact the Firm
January 08, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
BLRX INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm - BLRX
January 08, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against BioLineRx Ltd. (BLRX)
January 06, 2023
From
Robbins LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of BioLineRx Ltd. (BLRX) on Behalf of Investors
January 06, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
January 06, 2023
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
January 05, 2023
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of BioLineRx Ltd. Investors – BLRX
January 05, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
TOP RANKED ROSEN LAW FIRM Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX
December 29, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
NASDAQ:BLRX Shareholder Alert: Investigation over Potential Wrongdoing at BioLineRx Ltd.
November 16, 2022
San Diego, CA -- (SBWIRE) -- 11/16/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at BioLineRx Ltd.
Via
SBWire
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
September 20, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
September 19, 2022
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX
September 19, 2022
From
Rosen Law Firm
Via
Business Wire
Parkinson’s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027
May 05, 2021
Via
FinancialNewsMedia
Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
October 14, 2021
Palm Beach, FL – October 14, 2021 – FinancialNewsMedia.com News Commentary – The breast cancer drugs market, which has been steadily growing over the past few years, is projected to continue this trend...
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.